SCHEMBL5033141

SCHEMBL5033141

O=C(O)C1CCN(c2cccc(F)c2F)C1C1CCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HPGD P15428 1/20 0.37
ATM Q13315 1/20 0.36
LMNA P02545 2/20 0.33
MAPT P10636 1/20 0.33
C3AR1 Q16581 1/20 0.33
CHRM1 P11229 1/20 0.32
GRK2 P25098 1/20 0.32
CASP6 P55212 1/20 0.32
CASP8 Q14790 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HTT P42858 1/20 0.32
APEX1 P27695 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5133088 0.97 NOTUM (0.39) NOTUMKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL2034147 0.77 SMN1; SMN2 (0.46) NOTUMKMT2AMEN1ALDH1A1HPGD
SCHEMBL5033148 0.67 HTT (0.39) NOTUMKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL17609325 0.66 NOTUM (0.44) NOTUMKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL16759937 0.65 NOTUM (0.52) NOTUMKMT2AMEN1ALDH1A1MAPT
SCHEMBL2939478 0.65 SMN1; SMN2 (0.45) NOTUMKMT2AMEN1ALDH1A1MAPT
SCHEMBL5133092 0.64 HPGD (0.37) NOTUMKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL22463002 0.63 KDM4E (0.36) NOTUMALDH1A1HPGDATMKDM4E
SCHEMBL9106277 0.62 P2RX7 (0.44) NOTUMATMTDP1
SCHEMBL9105409 0.62 P2RX7 (0.44) NOTUMATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280879-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS PFIZER INC 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280879-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS XDH, CYP2D6, F12 NOTUM 3794/4885KMT2A 4414/4885MEN1 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.